# TOMOCLOUD

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tomocloud

- Industry: Medical Devices & Equipment
- Headquarters: Chiba-shi, Japan
- Website: www.tomocloud.co.jp
- Total disclosed funding: $0.3M
- Latest round: Seed (Dec 26, 2025)
- Investors on record: 1

## About

TOMOCLOUD Co., Ltd., based in Japan, specializes in developing and manufacturing innovative non-invasive bioimaging devices, improving health monitoring for patients and healthcare providers.Founded in 2025 in Chiba-shi, Japan, TOMOCLOUD Co., Ltd. manufactures bioimaging devices, primarily focusing on the LT Monitor Lite. The company has successfully completed one deal, raising JPY 50 million in a Seed round from UntroD Capital on December 26, 2025, which accounts for the total amount raised.TOMOCLOUD, Inc. specializes in developing and manufacturing non-invasive bioimaging devices, with its flagship product being the LT Monitor Lite. This device allows users to monitor swelling (edema) at home, addressing a significant gap in health monitoring by providing real-time data on physical conditions. Utilizing innovative electrical impedance tomography (EIT) technology, the LT Monitor Lite aids in the early detection and management of chronic conditions such as lymphedema. The company aims to empower healthcare providers, patients, and caregivers by offering accessible monitoring solutions designed for the global market.TOMOCLOUD generates revenue through direct sales of its bioimaging devices, primarily the LT Monitor Lite, to healthcare institutions and individual consumers. Their revenue model includes B2B transactions with hospitals and clinics, alongside direct-to-consumer sales. The pricing details are not disclosed, but the structure emphasizes accessibility and affordability, aiming to provide value to healthcare professionals and end users.In December 2025, TOMOCLOUD Co., Ltd. raised JPY 50 million in Seed funding from UntroD Capital, which will be used to accelerate product development, strengthen business operations, and establish quality management systems. The company plans to design and launch new products targeting various healthcare markets and is focused on establishing a broader geographic presence, though specific regions have yet to be detailed.

## Funding rounds

- Seed, Dec 26, 2025, $0.3M — UntroD Capital

## Investors

- UntroD Capital — Seed